NEW YORK  (GenomeWeb News) - AstraZeneca and the University of Manchester are placing a Clinical Research Fellow at DxS to work on a project to identify circulating DNA tumor markers in blood.
 
The focus of the three-year project will initially be to develop assays for genes that show prevalent mutations in cancer.  It is supported by AstraZeneca and Cancer Research UK.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.